Whole-genome sequencing reveals the molecular implications of the stepwise progression of lung adenocarcinoma

全基因组测序揭示了肺腺癌逐步进展的分子机制

阅读:2
作者:Yasuhiko Haga # ,Yoshitaka Sakamoto # ,Keiko Kajiya # ,Hitomi Kawai ,Miho Oka ,Noriko Motoi ,Masayuki Shirasawa ,Masaya Yotsukura ,Shun-Ichi Watanabe ,Miyuki Arai ,Junko Zenkoh ,Kouya Shiraishi ,Masahide Seki ,Akinori Kanai ,Yuichi Shiraishi ,Yasushi Yatabe ,Daisuke Matsubara ,Yutaka Suzuki ,Masayuki Noguchi ,Takashi Kohno ,Ayako Suzuki

Abstract

The mechanism underlying the development of tumors, particularly at early stages, still remains mostly elusive. Here, we report whole-genome long and short read sequencing analysis of 76 lung cancers, focusing on very early-stage lung adenocarcinomas such as adenocarcinoma in situ (AIS) and minimally invasive adenocarcinoma. The obtained data is further integrated with bulk and spatial transcriptomic data and epigenomic data. These analyses reveal key events in lung carcinogenesis. Minimal somatic mutations in pivotal driver mutations and essential proliferative factors are the only detectable somatic mutations in the very early-stage of AIS. These initial events are followed by copy number changes and global DNA hypomethylation. Particularly, drastic changes are initiated at the later AIS stage, i.e., in Noguchi type B tumors, wherein cancer cells are exposed to the surrounding microenvironment. This study sheds light on the pathogenesis of lung adenocarcinoma from integrated pathological and molecular viewpoints.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。